Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM
Phase 1
- Conditions
- Relapsed or Refractory Multiple Myeloma
- Interventions
- First Posted Date
- 2021-09-22
- Last Posted Date
- 2022-02-01
- Target Recruit Count
- 60
- Registration Number
- NCT05052970
- Locations
- 🇨🇳
Beijing Chaoyang Hospital, Capital Medical University, Beijing, Beijing, China
A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects
Phase 1
Completed
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2021-08-06
- Target Recruit Count
- 12
- Registration Number
- NCT04993222
- Locations
- 🇨🇳
Wuhan Medical Treatment Center, Wuhan, Hubei, China
Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients
Not Applicable
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Drug: Vyxeos、Daunorubicin Cytarabine liposome for injection
- First Posted Date
- 2021-06-09
- Last Posted Date
- 2021-06-09
- Target Recruit Count
- 16
- Registration Number
- NCT04920500
- Locations
- 🇨🇳
Institute of Hematology and Hospital of Blood Disease, Chinese Academy of Medical Sciences, Tianjin, China
© Copyright 2025. All Rights Reserved by MedPath